Of interest, various phytochemicals have been found to inhibit NLRP3 activation acting on different steps of the inflammasome cascade and to exert beneficial effects in experimental models of CNS diseases, including PD, AD, MS, and psychiatric disorders (Table 1 and Figure 4). This evidence concerns the gene NLRP3 and myeloid sarcoma.